Related Topics News -

     
 Title only   |   Print    Next page > 
     
藥明合聯抽高逾13% 獲瑞銀升目標價至94.6元兼上調每股盈測 野村稱中績穩固

2026-08-25T  
《業績》東曜藥業中期虧損5,852萬人民幣 盈轉虧

2026-08-23T  
《大行》大摩降藥明合聯目標價至80元 下調2026至30年盈測

2026-07-06T  
《業績》東曜藥業全年虧損1億人民幣 盈轉虧

2026-03-19T  
東曜藥業2025年度淨虧損1億人民幣

2026-03-03T  
《大行》野村升藥明合聯目標價至87.73元 料今年盈利升47%

2026-02-12T  
《大行》大摩:藥明合聯(02268.HK)提全購東曜藥業(01875.HK) 維持「增持」評級

2026-01-19T  
《大行》招銀國際升藥明合聯目標價至88元續籲「買入」 料盈利增長強勁

2026-01-19T  
《大行》大和:藥明合聯提全購東曜藥業 予藥明生「買入」評級

2026-01-16T  
東曜藥業急升57% 獲藥明合聯溢價60%要約收購

2026-01-15T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.